• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Depression in adults (update)

Depression: the treatment and management of depression in adults (update)

Status:	History
Publication date:	October 2009
Wave:	R
Process:	CG
Description:	Partial update of CG23 depression: management of depression in primary and secondary care.
Topic area: Mental health and behavioural conditions

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Christine Carson
Communications manager:	Sarita Tamber
Guidelines commissioning manager:	Claire Turner
Guidelines coordinator:	Marietta Smith
Patient involvement lead:	Victoria Thomas
Implementation lead:	Caroline Matenga
Lead collaborating centre:	National Collaborating Centre for Mental Health
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	03 September 2007
Consultation on draft scope with stakeholders:	28 August - 25 September 2007
Consultation on draft guideline with stakeholders:	24 Feb 2009 - 21 April 2009
Pre-publication check:	TBC
Publication date:	October 2009

Top

 

Project history

Date Update August 2007 The first draft of the scope is currently in preparation. The scope will define what aspects of care the guideline will cover and to who it will apply. 3 August 2007 List of stakeholders updated. 28 August 2007 The draft scope (see link below) is out for consultation with stakeholders. The scope defines what aspects of care the guideline will cover and to whom it will apply. If you wish to comment, you need to do so via one of the registered stakeholder organisations listed above, by the deadline shown. 25 September 2007 Consultation on the draft scope is complete and the scope is being modified in the light of comments received. When completed it will be posted on the website. It will define what aspects of care the guideline will cover and to whom it will apply. November 2007 The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table (see link below). The Guideline Development Group (GDG) oversees the development process. See below for a list of GDG members. November 2007 The NCCs may make a focussed call for evidence on specific clinical questions or subquestions, after it has done initial searches. It will be able to make a call at any point during development of the guideline, and stakeholders will usually be given 4 weeks to respond. The NCC will approach all registered stakeholders for this evidence. The NCC may not issue any calls for evidence for a guideline if the Guideline Development Group (GDG) feels it is not necessary. In addition, the NCCs will accept relevant confidential data for consideration by the GDG.  December 2007 Development of the clinical guideline is under way and is being led by the National Collaborating Centre. The Guideline Development Group meets regularly to oversee and assist the identification, review and synthesis of the evidence, the incorporation of expert consensus opinion and the translation of the evidence into recommendations for practice and audit criteria. Two versions of the guideline are under preparation: a full guideline and a NICE short-form guideline.  Please see timescales above for dates of consultation with stakeholders. 24 February 2009 The consultation draft of the guideline is out for consultation with registered stakeholders. Comments from non-registered organisations will not be considered. If you wish to comment, please do so via one of the registered stakeholder organisations listed below, by the deadline shown, or register your organisation at the following link: Stakeholder Registration page 21 April 2009 Consultation on the draft of the guideline is complete and the guideline is being modified in the light of comments received. 22 July 2009 The final draft of the full guideline is available for its pre-publication check. If you wish to report a factual error you need to do so via one of the registered stakeholder organisations listed, by the deadline shown.

Top

 

Key documents

Depression in adults (update): pre-publication comments table 28 October 2009 Depression in adults update: pre-publication check 21 July 2009 Depression in adults (update): list of stakeholders 08 September 2009 Depression in adults (update): draft guideline consultation 24 February 2009 Depression in adults (update): final scope 30 September 2008 Guidance development group 05 February 2008 Depression in adults (update): scope consultation 28 August 2007 The guideline development process - an overview for stakeholders, the public and the NHS (third edition) 25 April 2007 Stakeholder registration 21 April 2004 National Collaborating Centre for Mental Health 02 June 2003

This page was last updated: 30 March 2010